Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Issue of Equity

5 Apr 2024 15:49

RNS Number : 5598J
Maven Income and Growth VCT 5 PLC
05 April 2024
Β 

Maven Income and Growth VCT 5 PLC (the Company)

Β 

Issue of Equity

Β 

On 13 October 2023, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to Β£5 million, with an over-allotment facility for up to a further Β£2.5 million (the Offer).

Β 

Pursuant to the Offer, a total of Β£2,338,474 of valid applications were received in the period from 9.00am on 21 March 2024 up to and including 9.00am on 5 April 2024 in respect of the 2023/2024 tax year. This is the final allotment in respect of the 2023/2024 tax year and, as a result, the Company has issued and allotted 7,209,045 new Ordinary Shares on 5 April 2024. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 31.52p to 32.36p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 211,914,797. Therefore, the total number of voting rights in the Company is 211,914,797. The total amount raised by the Company for the 2023/2024 tax year to 5 April 2024 is Β£6,262,885.

Β 

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective, and dealings will commence, on or around 8 April 2024.

Β 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

The Board of the Company intends that an allotment in respect of applications for the 2024/2025 tax year will take place on, or around, 1 May 2024. For this allotment, and those made to date, the Company's Offer has received applications totalling Β£6,554,185.

Β 

For further information, please contact:

Β 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Β 

Maven Capital Partners UK LLP

Secretary

Β 

5 April 2024

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEQKPBQQBKDOQK
Date   Source Headline
27th Feb 20203:04 pmRNSTransaction in Own Shares
24th Feb 20203:55 pmRNSTransaction in Own Shares
19th Feb 20204:30 pmRNSTransaction in Own Shares
18th Feb 202011:35 amRNSNet Asset Value and Proposed Final Dividend
28th Jan 20204:53 pmRNSDirectorate Change and Appointment of New Chairman
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20192:06 pmRNSTransaction in Own Shares
7th Oct 20194:22 pmRNSTransaction in Own Shares
3rd Oct 20192:34 pmRNSNet Asset Value(s)
2nd Sep 20193:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:28 pmRNSIssue of Equity
30th Aug 20194:29 pmRNSNet Asset Value(s)
27th Aug 20192:55 pmRNSTransaction in Own Shares
31st Jul 20192:16 pmRNSTransaction in Own Shares
18th Jul 20195:05 pmRNSHalf-year Report
4th Jul 20193:29 pmRNSStatement re Net Asset Value and Interim Dividend
5th Jun 20194:15 pmRNSDirectorate Change
14th May 20192:01 pmRNSTransaction in Own Shares
30th Apr 20191:06 pmRNSResult of AGM
24th Apr 20199:50 amRNSIssue of Equity
4th Apr 20192:16 pmRNSHolding(s) in Company
4th Apr 201911:01 amRNSIssue of Equity - Replacement
4th Apr 20199:17 amRNSIssue of Equity
25th Mar 20194:09 pmRNSStatement re Offer for Subscription
13th Mar 201912:12 pmRNSTransaction in Own Shares
7th Mar 20195:50 pmRNSIssue of Equity
4th Mar 201912:40 pmRNSNet Asset Value(s)
28th Feb 20195:42 pmRNSAnnual Financial Report
20th Feb 201912:30 pmRNSStatement re Offer for Subscription
15th Jan 20194:17 pmRNSTransaction in Own Shares
11th Jan 20193:50 pmRNSHolding(s) in Company
21st Dec 20181:00 pmRNSDirector/PDMR Shareholding
21st Dec 201810:39 amRNSIssue of Equity
18th Dec 20184:17 pmRNSNet Asset Value
5th Nov 20184:52 pmRNSTransaction in Own Shares
2nd Nov 201811:38 amRNSResult of General Meeting
10th Oct 20185:06 pmRNSTransaction in Own Shares
8th Oct 20184:48 pmRNSTransaction in Own Shares
5th Oct 20184:04 pmRNSTransaction in Own Shares
4th Oct 20183:03 pmRNSTransaction in Own Shares
3rd Oct 20187:00 amRNSNet Asset Value(s)
26th Sep 20186:29 pmRNSStatement re Offer for Subscription
24th Jul 20184:58 pmRNSTransaction in Own Shares
20th Jul 20182:56 pmRNSHalf-year Report
18th Jul 20189:21 amRNSNet Asset Value(s)
18th Jul 20187:00 amRNSStatement re Offer for Subscription
2nd May 20184:59 pmRNSHolding(s) in Company
25th Apr 20184:39 pmRNSNet Asset Value(s)
24th Apr 20181:34 pmRNSResult of AGM
12th Mar 20187:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.